title: Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
abstract: BACKGROUND
  The frequency of monitoring glycated hemoglobin (HbA(1c)) and its impact on glycemic control of Chinese Type 2 diabetes mellitus (T2DM) patients have not been well understood.
  
  
  OBJECTIVE
  To explore the current status of the glycemic control, the frequency of HbA(1c) monitoring, and their relationship in T2DM outpatients in urban China.
  
  
  METHODS
  A cross-sectional study was carried out in 15 hospitals purposely sampled from 4 cities of China. T2DM outpatients were consecutively recruited, and underwent a face-to-face interview in outpatient consulting rooms using a self-developed structured questionnaire to collect information. All consented patients were invited to have a free HbA(1c) test.
  
  
  RESULTS
  Among 1511 subjects, the average level of HbA(1c) was 8.1±1.6% with the ideal percents of 13.6% and 24.8% (HbA(1c)<6.5% and <7.0%, respectively). Less than 1/3 (339/1157) had received 2 or more HbA(1c) tests per yr, and they had a significantly lower average of HbA(1c) than those having only 1 or no test per yr (F=5.012, p=0.007). After adjustment for possible confounders including age, gender, and city, there was a significantly inverse association with adjusted odds ratios of 2.56 [95% confidence interval (CI): 1.71, 3.86] and 1.67 (95% CI: 1.11, 2.50), respectively, between the frequency of monitoring HbA(1c) (null, once vs ≥2 times per yr) and worse glycemic control (HbA(1c)≥7.0%).
  
  
  CONCLUSIONS
  Glycemic control of T2DM outpatients was poor in urban China. Frequency of HbA(1c) monitoring is seriously insufficient in majority of patients. Lower frequency of HbA(1c) monitoring is significantly associated with poor glycemic control.
authors: School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
authors: C
authors: C
authors: Fu
authors: L
authors: L
authors: Ji
authors: W
authors: W
authors: Wang
authors: R
authors: R
authors: Luan
authors: W
authors: W
authors: Chen
authors: S
authors: S
authors: Zhan
authors: B
authors: B
authors: Xu
references: Ann Intern Med. 2004 Sep 21;141(6):421-31
references: 15381515
references: Value Health. 2009 Sep;12(6):923-9
references: 19824187
references: Saudi Med J. 2009 Dec;30(12):1551-6
references: 19936419
references: Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Jul;26(7):478-84
references: 16334996
references: Lancet. 1998 Sep 12;352(9131):837-53
references: 9742976
references: Lancet. 1998 Sep 12;352(9131):854-65
references: 9742977
references: Clin Cornerstone. 2007;8 Suppl 7:S19-29
references: 18159646
references: Diabetes Care. 2006 Jan;29 Suppl 1:S4-42
references: 16373931
references: Diabetologia. 2002 Jul;45(7):S13-7
references: 12136406
references: Chin Med J (Engl). 2008 Apr 20;121(8):677-81
references: 18701017
references: Diabetes Res Clin Pract. 2008 Dec;82(3):346-52
references: 18926583
references: Diabet Med. 2002 Dec;19(12):978-85
references: 12647837
references: Diabetes Care. 2009 Feb;32(2):227-33
references: 19033410
references: Diabetes Obes Metab. 2008 Jun;10 Suppl 1:8-15
references: 18435669
references: N Engl J Med. 2010 Mar 25;362(12):1090-101
references: 20335585
references: N Engl J Med. 2008 Jun 12;358(24):2560-72
references: 18539916
references: JAMA. 2001 Jan 10;285(2):182-9
references: 11176811